848328-57-4 Usage
Uses
Used in Pharmaceutical Industry:
2-((Benzyloxy)Methyl)cyclopropanecarboxylic acid is used as a synthetic intermediate for the production of a wide range of pharmaceuticals. Its unique structure and functional groups contribute to the development of various biologically active molecules.
Used in Organic Synthesis:
In the field of organic synthesis, 2-((Benzyloxy)Methyl)cyclopropanecarboxylic acid serves as a building block for the synthesis of complex organic compounds. Its cyclopropane core and reactive functional groups facilitate the creation of diverse chemical entities.
Used in Medicinal Chemistry:
2-((Benzyloxy)Methyl)cyclopropanecarboxylic acid is utilized in medicinal chemistry as a starting material for the synthesis of new drugs. Its structural features and reactivity make it a promising candidate for the development of innovative therapeutic agents.
Used in Drug Development:
2-((Benzyloxy)Methyl)cyclopropanecarboxylic acid has potential applications in the development of new drugs, particularly in the synthesis of biologically active molecules with therapeutic potential. Its unique properties and versatility in chemical reactions make it a valuable component in drug discovery processes.
Check Digit Verification of cas no
The CAS Registry Mumber 848328-57-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,3,2 and 8 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 848328-57:
(8*8)+(7*4)+(6*8)+(5*3)+(4*2)+(3*8)+(2*5)+(1*7)=204
204 % 10 = 4
So 848328-57-4 is a valid CAS Registry Number.
848328-57-4Relevant articles and documents
KRAS MUTANT PROTEIN INHIBITOR
-
, (2021/02/13)
A KRAS mutant protein inhibitor, as shown by formula (I), a composition containing the inhibitor and the use thereof.
Indoleamine-2,3-dioxygenase inhibitor as well as preparation method and application thereof
-
Paragraph 0089-0092; 0095-0097, (2019/08/12)
The invention provides a compound as shown in a formula (I). The invention also relates to a pharmaceutical composition containing the compound of the formula (I) and application of the compound to preparation of an indoleamine-2,3-dioxygenase (IDO) inhibitor drug. The compound prepared by the method of the invention has an obvious inhibiting effect on IDO protease and is stable in metabolism in vivo. The compound or a pharmaceutical composition thereof provided by the invention can be used for preparing the IDO inhibitor drug, and can also be used for preparing medicines for preventing and/ortreating diseases with pathological characteristics of an IDO-mediated tryptophan metabolic pathway.
HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS
-
Page/Page column 138, (2010/02/11)
Described are heterobicyclic compounds such as 4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid amides, 4,7-dihydro-5H-thieno[2,3-c]thiopyran- 3-carboxylic acid amides, 4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid amides, or benzo[b]thiophene